Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sabita Sankar
Observed names:
S Sankar,
Sabita SANKAR
Institutions:
Sanford Burnham Prebys Medical Discovery Institute,
Celgene (United States)
Observed institutions:
National University of Singapore,
Duke University,
Sanford Burnham Prebys Medical Discovery Institute,
Purdue University West Lafayette,
Yale University,
Duke Medical Center,
Celgene (United States),
Institute of Molecular and Cell Biology
show all 8
OpenAlex ID:
A5111592343
Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor.
1998
·
P Lin
, S Sankar
, et al.
·
PubMed
·
212
Functional Significance of Tie2 Signaling in the Adult Vasculature
2004
·
K. G. Peters
, Christopher D Kontos
, et al.
·
Recent Progress in Hormone Research
·
189
PDF
REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A–DDB1 ubiquitin ligase
2009
·
Samiksha Katiyar
, Enbo Liu
, et al.
·
EMBO Reports
·
167
Expression of Transforming Growth Factor Type III Receptor in Vascular Endothelial Cells Increases Their Responsiveness to Transforming Growth Factor β2
1995
·
Sabita Sankar
, Negar Mahooti-Brooks
, et al.
·
Journal of Biological Chemistry
·
150
PDF
HCPTPA, a Protein Tyrosine Phosphatase That Regulates Vascular Endothelial Growth Factor Receptor-mediated Signal Transduction and Biological Activity
1999
·
Liwen Huang
, Sabita Sankar
, et al.
·
Journal of Biological Chemistry
·
98
Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115
2015
·
Deborah S. Mortensen
, Sophie M. Perrin-Ninkovic
, et al.
·
Journal of Medicinal Chemistry
·
79
CC-115, a dual inhibitor of mTOR kinase and DNA-PK, blocks DNA damage repair pathways and selectively inhibits ATM-deficient cell growth in vitro
2017
·
Toshiya Tsuji
, Lisa M. Sapinoso
, et al.
·
Oncotarget
·
70
PDF
IKK-i signals through IRF3 and NFκB to mediate the production of inflammatory cytokines
2005
·
Sabita Sankar
, Henry Chan
, et al.
·
Cellular Signalling
·
62
CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo Characterization
2015
·
Deborah S. Mortensen
, Kimberly E. Fultz
, et al.
·
Molecular Cancer Therapeutics
·
57
PDF
Discovery of Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor CC-223
2015
·
Deborah S. Mortensen
, Sophie M. Perrin-Ninkovic
, et al.
·
Journal of Medicinal Chemistry
·
36
Discovery and SAR exploration of a novel series of imidazo[4,5-b]pyrazin-2-ones as potent and selective mTOR kinase inhibitors
2011
·
Deborah S. Mortensen
, Sophie M. Perrin-Ninkovic
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
35
Antisense oligonucleotide inhibition of encephalomyocarditis virus RNA translation
1989
·
Sabita SANKAR
, Keat‐Chye CHEAH
, et al.
·
European Journal of Biochemistry
·
30
PDF
Use of core modification in the discovery of CC214-2, an orally available, selective inhibitor of mTOR kinase
2013
·
Deborah S. Mortensen
, John Sapienza
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
26
CC-4047 promotes Th1 cell differentiation and reprograms polarized human Th2 cells by enhancing transcription factor T-bet
2008
·
Weiming Xu
, Maria Celeridad
, et al.
·
Clinical Immunology
·
26
Expression and processing of human rhinovirus type 14 polypeptide precursors in Escherichia coli maxicells
1988
·
Keat-Chye Cheah
, Sabita Sankar
, et al.
·
Gene
·
10
Potentially actionable kinase fusions in inflammatory myofibroblastic tumors.
2013
·
Christine Marie Lovly
, Doron Lipson
, et al.
·
Journal of Clinical Oncology
·
6
The biphasic effects of transforming growth factors in angiogenesis
1997
·
Joseph A Madri
, Sabita Sankar
·
Oxford University Press eBooks
·
5
Abstract A165: Antitumor activity of mTOR kinase inhibitor CC-223 in a mouse model of prostate cancer.
2013
·
Rama Krishna Narla
, Sophie Peng
, et al.
·
Molecular Cancer Therapeutics
·
2
Abstract 3229: Validation of Illumina TruSeq Amplicon Cancer Panel with concordance testing using Ion AmpliSeq Cancer Panel and other methods.
2013
·
Peng Fang
, Zhenyu Yan
, et al.
·
Cancer Research
·
2
A Novel mTOR Kinase Inhibitor Causes Growth Inhibition, Cell Cycle Arrest, Apoptosis and Autophagic Cell Death in Mantle Cell Lymphoma Cell Lines: A Distinct Profile from Rapamycin.
2008
·
Weiming Xu
, Christine Kang
, et al.
·
Blood
·
2
Angiogenesis
1988
·
Joseph A. Madri
, Sabita Sankar
, et al.
·
Springer eBooks
·
2
Data from CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo Characterization
2023
·
Deborah S. Mortensen
, Kimberly E. Fultz
, et al.
Supplementary Figures S1-S3, Tables S1-S7 from CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo Characterization
2023
·
Deborah S. Mortensen
, Kimberly E. Fultz
, et al.
Data from CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo Characterization
2023
·
Deborah S. Mortensen
, Kimberly E. Fultz
, et al.
Abstract B297: Clinical assessment of MUC1 protein expression in FFPE tissue: Developent and validation of an immunohistochemistry assay as a predictive assay for response to MUC1 vaccines.
2013
·
Sabita Sankar
, Jennifer Wright
, et al.
·
Molecular Cancer Therapeutics
Show more works
View as search
Works count:
33
Citation count:
1,266
H-index:
14
I10-index:
15
Year
Topic
Type